My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Using animal models to determine the significance of complement activation in Alzheimer's disease.

    Loeffler DA.

    J Neuroinflammation. 2004 Oct 12;1(1):18.PMID: 15479474 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Plaque complement activation and cognitive loss in Alzheimer's disease.

    Loeffler DA, Camp DM, Bennett DA.

    J Neuroinflammation. 2008 Mar 11;5:9.PMID: 18334032 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.

    Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ.

    J Neurochem. 2008 Sep;106(5):2080-92. Epub 2008 Jul 9.PMID: 18624920 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The complement cascade in Alzheimer's disease.

    Brunden KR, Benzing WC.

    Drug News Perspect. 1998 Mar;11(2):98-103.PMID: 15616657 [PubMed]Related articles

    5.

    A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.

    Bharathi, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, Rao KS.

    Brain Res Rev. 2006 Sep;52(2):275-92. Epub 2006 Jun 16. Review.PMID: 16782202 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Alzheimer's disease: new prospects in therapy and applied experimental models]

    Kubis AM, Janusz M.

    Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish. PMID: 18688208 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

    Fonseca MI, Ager RR, Chu SH, Yazan O, Sanderson SD, LaFerla FM, Taylor SM, Woodruff TM, Tenner AJ.

    J Immunol. 2009 Jul 15;183(2):1375-83. Epub 2009 Jun 26.PMID: 19561098 [PubMed - indexed for MEDLINE]Related articles

    8.

    Neuroinflammation in Alzheimer's disease: protector or promoter?

    Zilka N, Ferencik M, Hulin I.

    Bratisl Lek Listy. 2006;107(9-10):374-83. Review.PMID: 17262990 [PubMed - indexed for MEDLINE]Related articles

    9.

    Neuroglial-mediated immunoinflammatory responses in Alzheimer's disease: complement activation and therapeutic approaches.

    Chen S, Frederickson RC, Brunden KR.

    Neurobiol Aging. 1996 Sep-Oct;17(5):781-7.PMID: 8892352 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

    Streit WJ, Braak H, Xue QS, Bechmann I.

    Acta Neuropathol. 2009 Oct;118(4):475-85. Epub 2009 Jun 10.PMID: 19513731 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.

    Benveniste H, Ma Y, Dhawan J, Gifford A, Smith SD, Feinstein I, Du C, Grant SC, Hof PR.

    Ann N Y Acad Sci. 2007 Feb;1097:12-29. Review.PMID: 17413006 [PubMed - indexed for MEDLINE]Related articles

    13.

    Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.

    Zhao Z, Ho L, Wang J, Qin W, Festa ED, Mobbs C, Hof P, Rocher A, Masur S, Haroutunian V, Pasinetti GM.

    FASEB J. 2005 Dec;19(14):2081-2. Epub 2005 Sep 26.PMID: 16186174 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Caspase Activation in the Alzheimer's Disease Brain: Tortuous and Torturous.

    Rohn TT, Rissman RA, Head E, Cotman CW.

    Drug News Perspect. 2002 Nov;15(9):549-557.PMID: 12677194 [PubMed - as supplied by publisher]Related articles

    15.

    The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.

    Rozemuller AJ, van Gool WA, Eikelenboom P.

    Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):223-33. Review.PMID: 15975026 [PubMed - indexed for MEDLINE]Related articles

    16.

    Yin and Yang: complement activation and regulation in Alzheimer's disease.

    Shen Y, Meri S.

    Prog Neurobiol. 2003 Aug;70(6):463-72. Review.PMID: 14568360 [PubMed - indexed for MEDLINE]Related articles

    17.

    Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

    Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

    Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.PMID: 15977985 [PubMed - indexed for MEDLINE]Related articles

    18.

    Alzheimer's neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes.

    MacDonald AB.

    Med Hypotheses. 2007;68(4):822-5. Epub 2006 Oct 20.PMID: 17055667 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?

    Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, Yamaguchi H, Westmoreland SV, Mansfield KG.

    Rejuvenation Res. 2008 Apr;11(2):321-32.PMID: 18341428 [PubMed - indexed for MEDLINE]Related articles

    20.

    Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

    Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

    Neuroscientist. 2007 Feb;13(1):38-48. Review.PMID: 17229974 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk